IBDEI0ON ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11000,2)
 ;;=^5005592
 ;;^UTILITY(U,$J,358.3,11001,0)
 ;;=H35.82^^77^720^23
 ;;^UTILITY(U,$J,358.3,11001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11001,1,3,0)
 ;;=3^Retinal Ischemia/Cotton Wool Spot
 ;;^UTILITY(U,$J,358.3,11001,1,4,0)
 ;;=4^H35.82
 ;;^UTILITY(U,$J,358.3,11001,2)
 ;;=^5005716
 ;;^UTILITY(U,$J,358.3,11002,0)
 ;;=H35.61^^77^720^21
 ;;^UTILITY(U,$J,358.3,11002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11002,1,3,0)
 ;;=3^Retinal Hemorrhage,Right Eye
 ;;^UTILITY(U,$J,358.3,11002,1,4,0)
 ;;=4^H35.61
 ;;^UTILITY(U,$J,358.3,11002,2)
 ;;=^5005699
 ;;^UTILITY(U,$J,358.3,11003,0)
 ;;=H35.62^^77^720^22
 ;;^UTILITY(U,$J,358.3,11003,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11003,1,3,0)
 ;;=3^Retinal Hemorrhage,Left Eye
 ;;^UTILITY(U,$J,358.3,11003,1,4,0)
 ;;=4^H35.62
 ;;^UTILITY(U,$J,358.3,11003,2)
 ;;=^5005700
 ;;^UTILITY(U,$J,358.3,11004,0)
 ;;=H35.051^^77^720^24
 ;;^UTILITY(U,$J,358.3,11004,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11004,1,3,0)
 ;;=3^Retinal Neovascularization,Right Eye
 ;;^UTILITY(U,$J,358.3,11004,1,4,0)
 ;;=4^H35.051
 ;;^UTILITY(U,$J,358.3,11004,2)
 ;;=^5005598
 ;;^UTILITY(U,$J,358.3,11005,0)
 ;;=H35.052^^77^720^25
 ;;^UTILITY(U,$J,358.3,11005,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11005,1,3,0)
 ;;=3^Retinal Neovascularization,Left Eye
 ;;^UTILITY(U,$J,358.3,11005,1,4,0)
 ;;=4^H35.052
 ;;^UTILITY(U,$J,358.3,11005,2)
 ;;=^5005599
 ;;^UTILITY(U,$J,358.3,11006,0)
 ;;=H35.071^^77^720^26
 ;;^UTILITY(U,$J,358.3,11006,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11006,1,3,0)
 ;;=3^Retinal Telangiectasis,Right Eye
 ;;^UTILITY(U,$J,358.3,11006,1,4,0)
 ;;=4^H35.071
 ;;^UTILITY(U,$J,358.3,11006,2)
 ;;=^5005606
 ;;^UTILITY(U,$J,358.3,11007,0)
 ;;=H35.072^^77^720^27
 ;;^UTILITY(U,$J,358.3,11007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11007,1,3,0)
 ;;=3^Retinal Telangiectasis,Left Eye
 ;;^UTILITY(U,$J,358.3,11007,1,4,0)
 ;;=4^H35.072
 ;;^UTILITY(U,$J,358.3,11007,2)
 ;;=^5005607
 ;;^UTILITY(U,$J,358.3,11008,0)
 ;;=H35.061^^77^720^28
 ;;^UTILITY(U,$J,358.3,11008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11008,1,3,0)
 ;;=3^Retinal Vasculitis,Right Eye
 ;;^UTILITY(U,$J,358.3,11008,1,4,0)
 ;;=4^H35.061
 ;;^UTILITY(U,$J,358.3,11008,2)
 ;;=^5005602
 ;;^UTILITY(U,$J,358.3,11009,0)
 ;;=H35.062^^77^720^29
 ;;^UTILITY(U,$J,358.3,11009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11009,1,3,0)
 ;;=3^Retinal Vasculitis,Left Eye
 ;;^UTILITY(U,$J,358.3,11009,1,4,0)
 ;;=4^H35.062
 ;;^UTILITY(U,$J,358.3,11009,2)
 ;;=^5005603
 ;;^UTILITY(U,$J,358.3,11010,0)
 ;;=H34.8110^^77^720^11
 ;;^UTILITY(U,$J,358.3,11010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11010,1,3,0)
 ;;=3^Central Retinal Vein Occls,Right Eye w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,11010,1,4,0)
 ;;=4^H34.8110
 ;;^UTILITY(U,$J,358.3,11010,2)
 ;;=^5138476
 ;;^UTILITY(U,$J,358.3,11011,0)
 ;;=H34.8111^^77^720^12
 ;;^UTILITY(U,$J,358.3,11011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11011,1,3,0)
 ;;=3^Central Retinal Vein Occls,Right Eye w/ NV
 ;;^UTILITY(U,$J,358.3,11011,1,4,0)
 ;;=4^H34.8111
 ;;^UTILITY(U,$J,358.3,11011,2)
 ;;=^5138477
 ;;^UTILITY(U,$J,358.3,11012,0)
 ;;=H34.8112^^77^720^13
 ;;^UTILITY(U,$J,358.3,11012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11012,1,3,0)
 ;;=3^Central Retinal Vein Occls,Right Eye,Stable
 ;;^UTILITY(U,$J,358.3,11012,1,4,0)
 ;;=4^H34.8112
 ;;^UTILITY(U,$J,358.3,11012,2)
 ;;=^5138478
